HUT77876A - Eljárás fokozott antigénaktivitású bélbaktériumok és azokat tartalmazó vakcinák előállítására - Google Patents

Eljárás fokozott antigénaktivitású bélbaktériumok és azokat tartalmazó vakcinák előállítására Download PDF

Info

Publication number
HUT77876A
HUT77876A HU9702303A HU9702303A HUT77876A HU T77876 A HUT77876 A HU T77876A HU 9702303 A HU9702303 A HU 9702303A HU 9702303 A HU9702303 A HU 9702303A HU T77876 A HUT77876 A HU T77876A
Authority
HU
Hungary
Prior art keywords
bacterium
intestinal
shigella
intestinal bacterium
bacteria
Prior art date
Application number
HU9702303A
Other languages
English (en)
Hungarian (hu)
Inventor
Steven M. Frey
John L. Pace
Richard I. Walker
Original Assignee
Antex Biologics Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,543 external-priority patent/US5681736A/en
Application filed by Antex Biologics Inc., filed Critical Antex Biologics Inc.,
Publication of HUT77876A publication Critical patent/HUT77876A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045—Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU9702303A 1994-10-05 1995-10-04 Eljárás fokozott antigénaktivitású bélbaktériumok és azokat tartalmazó vakcinák előállítására HUT77876A (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines

Publications (1)

Publication Number Publication Date
HUT77876A true HUT77876A (hu) 1998-09-28

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9702303A HUT77876A (hu) 1994-10-05 1995-10-04 Eljárás fokozott antigénaktivitású bélbaktériumok és azokat tartalmazó vakcinák előállítására

Country Status (16)

Country Link
EP (1) EP0804542A4 (de)
JP (1) JP3394047B2 (de)
CN (1) CN1168693A (de)
AU (1) AU704283B2 (de)
BR (1) BR9509276A (de)
CA (1) CA2202027A1 (de)
CZ (1) CZ104397A3 (de)
FI (1) FI971403L (de)
HU (1) HUT77876A (de)
IL (1) IL115521A0 (de)
MX (1) MX9702431A (de)
NO (1) NO971519L (de)
NZ (1) NZ295907A (de)
PL (1) PL182700B1 (de)
SG (2) SG73509A1 (de)
WO (1) WO1996011258A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255064T3 (es) * 1994-10-05 2006-06-16 Emergent Immunosolutions Inc. Procedimientos de produccion de helicobacter sp antigenico potenciado y vacunas que comprenden el mismo.
CN102304527A (zh) * 2003-05-30 2012-01-04 英特塞尔股份公司 肠球菌抗原
WO2007108903A2 (en) * 2006-03-17 2007-09-27 Cerebus Biologicals, Inc. Campylobacter vaccines and methods of use
EP2161035B1 (de) * 2007-05-28 2019-08-21 Daiichi Sankyo Company, Limited Ganzzellige imfpstoffzusammensetzung mit bordetella parapertussis
CN107513553B (zh) * 2017-09-18 2021-05-18 江南大学 一种筛选具有拮抗空肠弯曲杆菌感染功能的乳酸菌的方法
CN109633151B (zh) * 2018-12-26 2022-03-11 西北农林科技大学 一种肠炎沙门氏菌检测方法、试纸条及应用
US12403187B2 (en) 2018-12-31 2025-09-02 Bellevacc As Bacterial vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06503231A (ja) * 1991-09-18 1994-04-14 アムジエン・インコーポレーテツド 胆汁酸塩を含有するｂ型肝炎ワクチン製剤

Also Published As

Publication number Publication date
NO971519L (no) 1997-05-27
EP0804542A4 (de) 1998-10-28
PL319580A1 (en) 1997-08-18
BR9509276A (pt) 1997-11-18
SG73510A1 (en) 2000-06-20
EP0804542A1 (de) 1997-11-05
CN1168693A (zh) 1997-12-24
JPH10507347A (ja) 1998-07-21
FI971403A0 (fi) 1997-04-04
IL115521A0 (en) 1996-06-18
SG73509A1 (en) 2000-06-20
PL182700B1 (pl) 2002-02-28
JP3394047B2 (ja) 2003-04-07
FI971403A7 (fi) 1997-06-04
CZ104397A3 (cs) 1998-06-17
NO971519D0 (no) 1997-04-03
AU3956195A (en) 1996-05-02
NZ295907A (en) 1999-04-29
WO1996011258A1 (en) 1996-04-18
AU704283B2 (en) 1999-04-15
MX9702431A (es) 1998-05-31
CA2202027A1 (en) 1996-04-18
FI971403L (fi) 1997-06-04

Similar Documents

Publication Publication Date Title
US5869066A (en) Vaccine containing a campylobacter bacterium having an enhanced antigenic property
Law Adhesion and its role in the virulence of enteropathogenic Escherichia coli
AU663858B2 (en) Diagnostic testing for campylobacter jejuni or coli infections using antigens
CZ20003470A3 (cs) Zeslabená bakterie nevratnou mutací, vakcina, která ji obsahuje a její použití
HUT77574A (hu) Eljárás fokozott antigénaktivitású Helicobacter sp. és azt tartalmazó vakcina előállítására
JP3394047B2 (ja) 増強された抗原性腸内細菌の作出方法およびそれを含むワクチン
WO1996011257A9 (en) Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same
WO1996011258A9 (en) Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same
KR20120129777A (ko) 약독화, 면역강화 살모넬라 엔테리티디스의 변이균주를 포함하는 살모넬라증 예방용 생균 백신 조성물
CN105307677A (zh) 弯曲杆菌疫苗
Davies Biochemical and cell-surface characteristics of Yersinia ruckeri in relation to the epizootiology and pathogeneis of infections in fish.
Fang Intestinal Escherichia coli infections
McDonald Genetic Manipulation of Campylobacter hepaticus and the Role of N-glycosylation in Spotty Liver Disease
Lockman Motility and adherence as Salmonella typhimurium virulence factors: The pathogenesis of fla, mot, andfim mutants in murine typhoid fever
Ngwai et al. Comparison of immunoblot analysis of emergent multidrug-resistant Salmonella typhimurium definitive phage type 104 with a non-multidrug-resistant definitive phage type 104 strain
Aziz Annotated bibliography on classical vibrio cholerae
Holmes Isolation and molecular characterisation of toxins from Campylobacter jejuni and related species
WO2002030321A2 (en) Bird diagnostics and treatments
Oldfield The genetic basis of lipopolysaccharide biosynthesis in Campylobacter jejuni